Cameron Turtle, CEO: Spyre Therapeutics SYRE Sell · Filed 25/11/05

Trade details

Type: Insider sale
Amount: $651,225.15
Shares · price: 28,155 sh · $23.13 a share
Held after: 718,752 sh
Stock: Spyre Therapeutics SYRE
Person: Cameron TurtleCEO
Trade date: 25/11/03
Filed: 25/11/05
Days to filing: 2 days

Sold 3.8% of holdings

Share of holding sold: 3.8%

Spyre Therapeutics trades, last 26 weeks

What else happened in Spyre Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/04~25/12/03

Cameron Turtle's recent trades

Cameron TurtleCEO
Planned sale10b5-1 planSpyre Therapeutics
Planned sale10b5-1 plan
Spyre Therapeutics
SYRE
$4M
45,000 sh
$4M
Filed 07/01
Traded 07/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$574.5K
8,149 sh
$574.5K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$246.9K
3,557 sh
$246.9K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$235.1K
3,294 sh
$235.1K
Filed 06/03
Traded 06/01
Cameron TurtleCEO
Sell10b5-1 planSpyre Therapeutics
Sell10b5-1 plan
Spyre Therapeutics
SYRE
$368.6K
5,300 sh
$368.6K
Filed 05/01
Traded 05/01